SEC Form 4 · accession 0001571049-16-013062
BNB PLUS CORP. · BNBX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Beth Jantzen
Officer — Chief Financial Officer
Period of report
Jun 16, 2015
Accepted (ET)
Mar 15, 2016 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000744452
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $3.45 | Jun 16, 2015 | A | 30,000 | A | — | Feb 14, 2025 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The grant of options was approved by a committee of the board of directors of Applied DNA Sciences, Inc. (the "Company") effective February 15, 2015, subject to stockholder approval of an amendment to the Company's equity incentive plan under which the options were granted. The Company's stockholders approved such amendment on June 16, 2015.
- F225% of these options vest and become exercisable each anniversary over four years, commencing on February 15, 2016, one year from the date of grant.